Anatomic Pathology Market Shows Strong Growth with Leading Players
The renewed focus on anatomic pathology is linked to a
deeper focus on better understanding bodily functions as well as the impact of
various diseases on the body. Market reports associated to the healthcare
industry have been made available by Market Research Future which creates
reports on other industry verticals that outlines the current market scenarios.
The anatomic
pathology market is projected to earn about USD 22 billion approximately in
the duration of the forecast period.
The availability of better laboratory and pathological
services is increasing the pace of growth of the market. The benefit extended
by anatomic pathology in understanding the effect of diseases helps doctors and
pharma companies to understand the impact of the disease better and suggest
appropriate and safe treatment methods. The development in the practice of
postmortem procedures is boosting the expansion of the market considerably. The
escalating demand for AP and molecular oncology services in the healthcare
sector is expected to raise the opportunities for market expansion.
Request
Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/2409
Segmental Analysis
The anatomic pathology market is segmented on the basis of
type, region, and application. On the basis of type, the market is segmented
into consumable, instruments, and services. On the basis of application, the
market is segmented into disease diagnostic for diseases such as lymphoma,
cancer and others, drug discovery and developments. The market segmentation on
the basis of end users comprises of clinical office laboratories, hospitals,
physician office laboratory, and others. The regions that are a part of the
market are Middle East, North America, Asia Pacific, Europe, and Africa.
Detailed Regional Analysis
The regional analysis of the anatomic pathology market
comprises of regions such as the Middle East, North America, Asia Pacific,
Europe, and Africa. The North American region is observed to be the principal
market for anatomic pathology. The European region is the next key market. Additionally,
the Asia Pacific market is observed to be the fastest increasing market for
anatomic pathology in the duration for the forecast period.
Competitive Analysis
The plan formulation methods in the market have become
considerably easier in which deviations are well accounted for; this approach
increases the overall success of these plans in the market. The market is also
well equipped to meet the challenges and keep up with the dynamic growth trends
effectively. The evolution patterns are reviewed in tandem to the customer
likings to realize the greatest growth, and in the long run, viability. The
framework for growth plans also has stimulated the market for potential new
entrants. The alterations seen in terms of strategy implementation and creation
are adapting the development pace of the market. The market contenders are
making considerable adjustments to minimize the incidence of competitive
disadvantage. The leadership trends in the market are reinforcing the level of
growth that can be achieved in the present market scenario.
The noteworthy contenders shaping the market of anatomic
pathology are Agilent Technologies, Oxford Cancer Biomarkers, Abbott
Diagnostics, Danaher, Roche Diagnostics, Abcam, Janssen Diagnostic, Advanced
Cell Diagnostics, Agendia, Thermo Fisher Scientific, SAKURA FINETEK USA, Tecan,
Angsana Molecular & Diagnostics Laboratory, AutoGenomics, Monogram
Biosciences, Biocartis, Nucleix, CellMax Life, Biocare Medical, AdnaGen, Cancer
Genetics, Digipath, Enzo Biochem, Epic Sciences, Omnyx, RareCyte, and
VolitionRx. e t c
Industry Updates:
Sep 2018 Quest Diagnostics has acquired PhenoPath, a US
-based specialized anatomic pathology provider, PhenoPath will operate as part
of AmeriPath, a wholly owned Quest pathology services business. Its services,
together with molecular oncology, will supplement Quest’s own Advanced
Diagnostics portfolio. The transaction is also likely to deepen Quest
Diagnostics’ presence in Pacific Northwest. The PhenoPath business will
function as part of Quest Diagnostics’ wholly owned business, AmeriPath, an
important provider of AP services.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/anatomic-pathology-market-2409
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment